Clinical Trial Update: Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing tofacitinib with prednisolone for active Takayasu's arteritis is reported, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Prednisolone (Prednisolone)
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Takayasu Arteritis | Phase 3 | Status: UNKNOWN